Logo image of ALBPS.PA

BIOPHYTIS (ALBPS.PA) Stock Price, Quote, News and Overview

EPA:ALBPS - Euronext Paris - Matif - FR001400OLP5 - Common Stock - Currency: EUR

0.3  +0 (+1.35%)

ALBPS.PA Quote, Performance and Key Statistics

BIOPHYTIS

EPA:ALBPS (3/7/2025, 7:00:00 PM)

0.3

+0 (+1.35%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High2.04
52 Week Low0.25
Market Cap3.44M
Shares11.46M
Float11.40M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)04-07 2025-04-07/amc
IPO07-13 2015-07-13


ALBPS.PA short term performance overview.The bars show the price performance of ALBPS.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30

ALBPS.PA long term performance overview.The bars show the price performance of ALBPS.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of ALBPS.PA is 0.3 EUR. In the past month the price increased by 2.92%. In the past year, price decreased by -81.71%.

BIOPHYTIS / ALBPS Daily stock chart

ALBPS.PA Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 21.07 346.68B
1ABBV.MI ABBVIE INC 20.82 342.48B
AMG.DE AMGEN INC 16.43 161.21B
1AMGN.MI AMGEN INC 15.84 160.89B
1GILD.MI GILEAD SCIENCES INC 25.67 135.84B
GIS.DE GILEAD SCIENCES INC 25.39 134.40B
VX1.DE VERTEX PHARMACEUTICALS INC 1667.04 115.58B
ARGX.BR ARGENX SE 253.61 33.75B
22UA.DE BIONTECH SE-ADR N/A 24.36B
IDP.DE BIOGEN INC 9.25 20.54B
1BIIB.MI BIOGEN INC 8.39 19.21B
0QF.DE MODERNA INC N/A 13.19B

About ALBPS.PA

Company Profile

ALBPS logo image Biophytis SA is a FR-based company operating in Biotechnology industry. The company is headquartered in Paris, Ile-De-France and currently employs 22 full-time employees. The company went IPO on 2015-07-13. Biophytis SA, formerly Institut Biophytis Sas is a France-based company engaged in the healthcare industry. The firm is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.

Company Info

BIOPHYTIS

14 avenue de l'Opera

Paris ILE-DE-FRANCE FR

Employees: 22

Company Website: https://www.biophytis.com/

Investor Relations: http://www.biophytis.com/en/action/operation-publique-de-bsa/

Phone: 33141836600

BIOPHYTIS / ALBPS.PA FAQ

What is the stock price of BIOPHYTIS today?

The current stock price of ALBPS.PA is 0.3 EUR. The price increased by 1.35% in the last trading session.


What is the ticker symbol for BIOPHYTIS stock?

The exchange symbol of BIOPHYTIS is ALBPS and it is listed on the Euronext Paris - Matif exchange.


On which exchange is ALBPS.PA stock listed?

ALBPS.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for BIOPHYTIS stock?

9 analysts have analysed ALBPS.PA and the average price target is 0.84 EUR. This implies a price increase of 178.8% is expected in the next year compared to the current price of 0.3. Check the BIOPHYTIS stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BIOPHYTIS worth?

BIOPHYTIS (ALBPS.PA) has a market capitalization of 3.44M EUR. This makes ALBPS.PA a Nano Cap stock.


How many employees does BIOPHYTIS have?

BIOPHYTIS (ALBPS.PA) currently has 22 employees.


What are the support and resistance levels for BIOPHYTIS (ALBPS.PA) stock?

BIOPHYTIS (ALBPS.PA) has a support level at 0.3 and a resistance level at 0.31. Check the full technical report for a detailed analysis of ALBPS.PA support and resistance levels.


Should I buy BIOPHYTIS (ALBPS.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BIOPHYTIS (ALBPS.PA) stock pay dividends?

ALBPS.PA does not pay a dividend.


When does BIOPHYTIS (ALBPS.PA) report earnings?

BIOPHYTIS (ALBPS.PA) will report earnings on 2025-04-07, after the market close.


What is the Price/Earnings (PE) ratio of BIOPHYTIS (ALBPS.PA)?

BIOPHYTIS (ALBPS.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-6.54).


ALBPS.PA Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to ALBPS.PA. When comparing the yearly performance of all stocks, ALBPS.PA is a bad performer in the overall market: 98.25% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ALBPS.PA Financial Highlights

Over the last trailing twelve months ALBPS.PA reported a non-GAAP Earnings per Share(EPS) of -6.54. The EPS decreased by -8080.37% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -172.99%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-8203%
Sales Q2Q%N/A
EPS 1Y (TTM)-8080.37%
Revenue 1Y (TTM)N/A

ALBPS.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to ALBPS.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.


Ownership
Inst OwnersN/A
Ins Owners0.28%
Short Float %N/A
Short RatioN/A
Analysts
Analysts84.44
Price Target0.84 (180%)
EPS Next Y65.17%
Revenue Next YearN/A